financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Xylem Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Xylem Inc.
May 4, 2026 9:56 AM

12:45 PM EDT, 05/04/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Following Q1 results, we trim our 12-month target to $140 from $160, applying a multiple more in line with the broader industrial machinery sub-industry. We value shares at 23.2x our 2027 EPS outlook of $6.02 (in line with previous forecast; 2026 EPS view revised to $5.52 from $5.50). XYL's organic revenues and orders were flat Y/Y, while adjusted EBITDA margins expanded by 20 bps and adjusted EPS increased by 9%. Measurement & Control saw a 15% increase in orders driven by smart metering demand, while Applied Water experienced a surge in orders related to data centers. These gains were offset by declines in the Water Infrastructure and Water Solutions & Services, which was impacted by strategic "walkaway" actions, softness in China, and timing of capital projects. We reiterate our Buy opinion on shares, though we do acknowledge heightened risk associated with a more back-half-weighted earnings guide, with Q3 and Q4 having higher expectations.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
May 11, 2026
08:00 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $43 to $229, valuing ALB at 27.1x on our 2027 EPS estimate, a premium to ALB's normalized average fwd P/E during the last...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
May 11, 2026
09:15 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target to $84 from $98, based on 16.9x our 2027 EPS estimate, below GMED's five-year average forward P/E multiple. We raise our 2026 EPS view to $4.72...
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
May 11, 2026
10:10 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price is unchanged at $189, valuing shares at 19.2x our next-12-month EPS estimate of $9.86, slightly below IPP peers averaging 19.5x but significantly above NRG's highly volatile...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
May 11, 2026
07:20 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $42, raised $2, reflects relative valuation and our DCF models. On a relative basis, we apply a 4.5x multiple of enterprise value to projected 2027...
Copyright 2023-2026 - www.financetom.com All Rights Reserved